Medtronic is a global leader in medical technology, focused on developing and providing innovative therapeutic solutions to improve the lives of patients. The company specializes in a wide range of medical devices and therapies, addressing conditions in areas such as diabetes care, cardiovascular health, surgical innovations, and neurological disorders. Medtronic is committed to advancing healthcare through cutting-edge research, collaboration with healthcare providers, and a strong emphasis on patient-centered care, aiming to enhance the quality of life for millions around the world. Read More
The most recent research report on the "Endoscopy Equipment Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forecasts
The most recent research report on the "Avascular Necrosis Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forecasts,
Medtronic (NYSE:MDT) reported what executives described as its strongest top-line performance in a decade, as growth in cardiac ablation, diabetes, medical-surgical products and select neuroscience platforms helped drive fiscal fourth-quarter and full-year results above expectations.
Chairman and C
Medtronic (MDT) to report Q4 2026 results on 6/3, expected revenue of $9.61B & EPS of $1.55. Recent acquisition of SPR Therapeutics adds to neuromodulation business. Analyst ratings show mixed opinions.
The most recent research report on the "Hemodialysis Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forecasts, and p
The most recent research report on the "Nitinol Medical Devices Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forec
